Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial

Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
doi: https://doi.org/10.1101/2021.11.20.21266229

Article usage

Article usage: November 2021 to March 2023

AbstractFullPdf
Nov 20211250541207
Dec 20211838380258
Jan 20226126735
Feb 20224182042
Mar 20221791017
Apr 2022100720
May 2022101916
Jun 202285818
Jul 20227616
Aug 202253314
Sep 202255017
Oct 202250617
Nov 202244012
Dec 202238614
Jan 202342823
Feb 202350234
Mar 202325248
Back to top
Posted November 25, 2021.
Download PDF
Data/Code
Email
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area